Bei Akademie registrieren
Regeneron, US75886F1075

Regeneron stock pre-market at EUR 717.70: research-based drugmaker

Published on 10/26/2026 at 08:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Regeneron develops medicines through research and development. At Lang & Schwarz, the stock trades pre-market at EUR 717.70 on October 26, 2026.

Business model and trading date

  • Regeneron develops medicines through research and development.
  • The pre-market quote is dated October 26, 2026.
  • Regeneron stock trades pre-market at EUR 717.70 at 8:14 a.m. CET at Lang & Schwarz on October 26, 2026.
Makroaufnahme einer transparenten Antikörper-Proteinstruktur in Blau- und Weißtönen
Regeneron Pharma US75886F1075 fokussiert eine detailreiche Makroaufnahme einer transparenten Antikörper-Proteinstruktur mit feinen Lichtreflexen, Illustration mit AI erstellt.

On October 26, 2026, Regeneron stock trades pre-market at EUR 717.70 at 8:14 a.m. CET at Lang & Schwarz.

Ahead of the Xetra open

The quote is in the pre-market phase before the Xetra session. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Regeneron stock.

Business and market context

Regeneron develops medicines through research and development, according to the company’s investor website.

Market context: Market report S&P 500.

More news and analysis on Regeneron stock

Disclaimer...
en | US75886F1075 | REGENERON | boerse | 70412606 | bgmi